Letter: Prolactin and prostaglandin synthesis

A Diet Enriched in α-Lipoic Acid Reverses the Age-Related Compromise in Antioxidant Defences in Rat Cortical Tissue.

Nutritional neuroscience·2016

Thromboxane A(2) as a possible natural ligand for benzodiazepine receptors.

Neuroscience letters·2009

Role of the fractalkine receptor CX3CR1 polymorphisms V249I and T280M as risk factors for early-onset coronary artery disease in patients with no classic risk factors.

Scandinavian journal of clinical and laboratory investigation·2008

The comparison of changes in behavior, neurochemistry, endocrine, and immune functions after different routes, doses and durations of administrations of IL-1beta in rats.

Pharmacopsychiatry·2006

Ethyl-EPA in Huntington disease: a double-blind, randomized, placebo-controlled trial.

Neurology·2005

Cerebral metabolism in male patients with schizophrenia who have seriously and dangerously violently offended: a 31P magnetic resonance spectroscopy study.

Prostaglandins, leukotrienes, and essential fatty acids·2004

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Heterologous Expression, Antihypertensive Effect, and Underlying Mechanism of Sequence-Designed ACE Inhibitory Peptide YWLKP.

Journal of agricultural and food chemistry·2026

Pro4S: Prediction of protein solubility by fusing sequence, structure, and surface.

Protein science : a publication of the Protein Society·2026

Linker domain Ser-phosphorylation as a putative modulator for ABCB alkaloid transporters.

Planta·2026

N-Terminal protein sequencing by nicotinic acid derivatization and MS analysis.

Analytical and bioanalytical chemistry·2026

Immunopharmacological mechanisms underlying SARS-CoV-2 spike-induced persistent pain in mice.

Brain, behavior, and immunity·2026

Repurposing nucleos(t)ide analogs as purine nucleoside phosphorylase inhibitors through Gaussian accelerated molecular dynamics simulations.

Biochemical and biophysical research communications·2026

Related Experiment Videos

Letter: Prolactin and prostaglandin synthesis

Related Concept Videos

A Diet Enriched in α-Lipoic Acid Reverses the Age-Related Compromise in Antioxidant Defences in Rat Cortical Tissue.

Thromboxane A(2) as a possible natural ligand for benzodiazepine receptors.

Role of the fractalkine receptor CX3CR1 polymorphisms V249I and T280M as risk factors for early-onset coronary artery disease in patients with no classic risk factors.

The comparison of changes in behavior, neurochemistry, endocrine, and immune functions after different routes, doses and durations of administrations of IL-1beta in rats.

Ethyl-EPA in Huntington disease: a double-blind, randomized, placebo-controlled trial.

Cerebral metabolism in male patients with schizophrenia who have seriously and dangerously violently offended: a 31P magnetic resonance spectroscopy study.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Heterologous Expression, Antihypertensive Effect, and Underlying Mechanism of Sequence-Designed ACE Inhibitory Peptide YWLKP.

Pro4S: Prediction of protein solubility by fusing sequence, structure, and surface.

Linker domain Ser-phosphorylation as a putative modulator for ABCB alkaloid transporters.

N-Terminal protein sequencing by nicotinic acid derivatization and MS analysis.

Immunopharmacological mechanisms underlying SARS-CoV-2 spike-induced persistent pain in mice.

Repurposing nucleos(t)ide analogs as purine nucleoside phosphorylase inhibitors through Gaussian accelerated molecular dynamics simulations.

Related Experiment Videos

Letter: Prolactin and prostaglandin synthesis

Related Concept Videos

Related Articles